Kenvue Inc. closed 4.37% below its 52-week high of $24.46, which the company achieved on November 26th.

Kenvue Inc., has announced a five-year collaboration with Microsoft which aims to transform digital operations through ...

The maker of Tylenol, a spinoff of J&J, has underperformed. But Kenvue could bounce back thanks to help from activist ...

Kenvue announced a five-year collaboration with Microsoft to transform digital operations through Artificial Intelligence (AI ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500 's dividend yield of 1 ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on ...

Kenvue (KVUE) entered a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence ...

Citi raised the firm’s price target on Kenvue (KVUE) to $22 from $21 and keeps a Neutral rating on the shares as part of a Q1 earnings preview ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with ...

The collaboration aims to establish a strong foundation for transforming digital operations through advanced AI technologies.

Shares of Kenvue Inc. KVUE advanced 2.81% to $22.71 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 5,405.97 and the ...